GFAP and Parkinson disease: Enteric glia display indications of a reactive phenotype such as increased GFAP expression in the 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) animal models of PD (181, 182).